Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-24 Purchase | 2023-11-28 06:55 am | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 5,000 | $3.07 | $15,350 | 9,501 (Direct) | View |
| 2023-09-15 Purchase | 2023-09-20 11:27 am | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 3,000 | $5.6137 | $16,841 | 4,501 (Direct) | View |
| 2021-02-16 Purchase | 2021-02-18 4:06 pm | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 10,000 | $2.2 | $22,000 | 30,000 (Direct) | View |
| 2020-12-18 Purchase | 2020-12-21 09:17 am | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 20,000 | $1.91 | $38,200 | 20,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-18 Option Award | 2021-05-20 4:37 pm | 2022-05-18 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 200,000 | $0 | 260,000 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:15 pm | 2021-08-19 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 30,000 | $0 | 60,000 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-25 7:18 pm | N/A 2030-06-25 | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-01-06 Disposition | 2020-01-06 1:33 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 309,362 | $0 | 0 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:55 pm | N/A 2027-02-28 | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 329,439 | $0 | 137,546 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:55 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 18,000 | $33.27 | 137,546 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:55 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 136,250 | $29.01 | 137,546 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:55 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 125,000 | $25.41 | 137,546 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:55 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 50,189 | $52.7 | 137,546 (Direct) | View |
| 2019-12-27 Tax Withholding | 2019-12-31 7:55 pm | N/A N/A | MEDICINES CO | MDCO | Wijngaard Peter Chief Development Officer | 224,341 | $84.78 | 137,546 (Direct) | View |